A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus
The purpose of this study is to determine whether albiglutide is effective in the treament of patients with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
Satna Monica, California 90404, United States
Downington, Pennsylvania 19335, United States
Sugarland, Texas 77479, United States
Virgina Beach, Virginia 23455, United States